Clinical Trials · NCT02920190
Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
- Phase
- Phase 4
- Recruitment status
- Withdrawn
- Sponsor
- University of Miami
- Enrollment
- 0
- Start date
- Sep 2020
- Locations
- See registry
- Primary endpoint
- Change in Epicardial Fat Thickness